+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Palliative Care - Global Strategic Business Report 2026

  • PDF Icon

    Report

  • 379 Pages
  • November 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 6068388
The global market for Palliative Care was valued at US$118.1 Billion in 2025 and is projected to reach US$213.7 Billion by 2032, growing at a CAGR of 8.9% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Palliative Care Market - Key Trends & Drivers Summarized

Why Is Palliative Care Becoming More Essential in Global Healthcare?

The demand for palliative care is increasing as the global population ages and the prevalence of chronic and life-limiting illnesses continues to rise. Palliative care plays a crucial role in improving the quality of life for patients with serious conditions such as cancer, cardiovascular diseases, neurodegenerative disorders, and advanced organ failure. As healthcare systems emphasize patient-centered care, the integration of palliative services into hospitals, hospices, and home-based settings has gained traction. Additionally, advancements in pain management, psychological support, and holistic therapies are enhancing the scope and accessibility of palliative care.

How Are Medical Innovations and Digital Health Transforming Palliative Care?

Technology is playing a key role in expanding access to palliative care services. The adoption of telemedicine, AI-driven symptom management, and remote patient monitoring has made palliative care more accessible, particularly in rural and underserved areas. Digital health platforms allow healthcare providers to coordinate patient care, offer virtual consultations, and optimize medication management. Additionally, the integration of wearable health devices enables real-time monitoring of vital signs, pain levels, and treatment effectiveness, allowing caregivers to provide timely interventions. The use of AI and predictive analytics is also helping healthcare professionals personalize treatment plans and anticipate patient needs more accurately.

What Challenges Exist in Expanding Palliative Care Services?

Despite its growing importance, palliative care faces challenges such as limited awareness, inadequate funding, and shortages of trained healthcare professionals. In many regions, palliative services are underdeveloped due to a lack of integration with primary healthcare systems and insufficient reimbursement policies. Additionally, cultural and social stigmas surrounding end-of-life care can prevent patients and families from seeking palliative services early in their disease progression. However, increasing advocacy efforts and policy reforms are gradually addressing these barriers, encouraging wider adoption of palliative care programs.

What's Fueling the Growth of the Palliative Care Market?

The growth in the palliative care market is driven by several factors, including the rising incidence of chronic illnesses, increasing healthcare expenditures on supportive care, and the expansion of home-based palliative care services. The shift toward value-based healthcare models and patient-centered treatment approaches is further promoting the integration of palliative care into mainstream medical practice. Additionally, government initiatives and non-profit organizations focused on palliative care awareness, training, and funding are strengthening healthcare infrastructure to support this essential medical service.

Report Scope

The report analyzes the Palliative Care market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Condition (Cancer, Dementia, HIV, Cerebrovascular Disease, Respiratory Disease, Other Conditions); Diagnostic Group (Non Communicable Diseases Group, Communicable Diseases Group, Injury Poisoning & External Causes Group, Maternal Perinatal & Nutritional Conditions Group); Provider Type (Home Based Providers, Hospitals & Clinics, Community Settings).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cancer segment, which is expected to reach US$75.1 Billion by 2032 with a CAGR of a 11.1%. The Dementia segment is also set to grow at 6.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $36.5 Billion in 2025, and China, forecasted to grow at an impressive 14.2% CAGR to reach $56.9 Billion by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Palliative Care Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Palliative Care Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Palliative Care Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as African Palliative Care Association (APCA), Asia Pacific Hospice Palliative Care Network (APHN), Canadian Hospice Palliative Care Association (CHPCA), Chinese Association for Life Care, European Association for Palliative Care (EAPC) and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Palliative Care market report include:

  • African Palliative Care Association (APCA)
  • Asia Pacific Hospice Palliative Care Network (APHN)
  • Canadian Hospice Palliative Care Association (CHPCA)
  • Chinese Association for Life Care
  • European Association for Palliative Care (EAPC)
  • German Association for Palliative Medicine (DGP)
  • Hospice and Palliative Nurses Association (HPNA)
  • Hospice UK
  • Indian Association of Palliative Care (IAPC)
  • International Association for Hospice & Palliative Care (IAHPC)
  • Italian Society for Palliative Care (SICP)
  • Japanese Society for Palliative Medicine (JSPM)
  • Korean Society for Hospice and Palliative Care
  • Latin American Association for Palliative Care (ALCP)
  • National Hospice and Palliative Care Organization (NHPCO)
  • New Zealand Palliative Care Council
  • Palliative Care Australia
  • Palliative Care South Africa (PCSSA)
  • Singapore Hospice Council
  • Worldwide Hospice Palliative Care Alliance (WHPCA)

What Sets This Report Apart From Others?

  • Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
  • Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
  • Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
  • Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
  • Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
  • Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Palliative Care - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Geriatric Population and Chronic Disease Burden Throw Spotlight on Palliative Care Needs
  • Shift Toward Home-Based and Community Care Expands Access to Palliative Services
  • Integration of Pain Management and Psychosocial Support Enhances Care Continuum
  • Government and Insurance Support Strengthen Business Case for Palliative Reimbursement
  • Technological Advancements in Remote Monitoring Drive Adoption in Home Settings
  • Increased Awareness of End-of-Life Planning Spurs Demand for Specialized Care Programs
  • Multidisciplinary Care Models Sustain Growth Across Acute and Long-Term Care Facilities
  • Cultural Acceptance and Patient-Centered Care Trends Enhance Service Adoption
  • Training Programs and Workforce Development Initiatives Address Caregiver Shortages
  • Telehealth and Virtual Palliative Care Services Expand Reach in Underserved Areas
  • Hospice and Palliative Care Mergers Create Scalable Service Networks
  • Oncology and Neurology Referrals Propel Demand for Integrated Palliative Pathways
  • Value-Based Healthcare Policies Drive Investments in Palliative Quality Metrics
  • Pharmaceutical Innovation in Pain and Symptom Control Supports Clinical Outcomes
  • NGO and Philanthropic Funding Boosts Palliative Infrastructure in Low-Resource Regions
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Palliative Care Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
  • Table 2: World Recent Past, Current & Future Analysis for Palliative Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 3: World Historic Review for Palliative Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 4: World 13-Year Perspective for Palliative Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
  • Table 5: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Dementia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Dementia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Dementia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for HIV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for HIV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for HIV by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 14: World Recent Past, Current & Future Analysis for Cerebrovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 15: World Historic Review for Cerebrovascular Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 16: World 13-Year Perspective for Cerebrovascular Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 17: World Recent Past, Current & Future Analysis for Respiratory Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 18: World Historic Review for Respiratory Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 19: World 13-Year Perspective for Respiratory Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 20: World Recent Past, Current & Future Analysis for Other Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 21: World Historic Review for Other Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 22: World 13-Year Perspective for Other Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 23: World Recent Past, Current & Future Analysis for Maternal Perinatal & Nutritional Conditions Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 24: World Historic Review for Maternal Perinatal & Nutritional Conditions Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 25: World 13-Year Perspective for Maternal Perinatal & Nutritional Conditions Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 26: World Recent Past, Current & Future Analysis for Non Communicable Diseases Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 27: World Historic Review for Non Communicable Diseases Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 28: World 13-Year Perspective for Non Communicable Diseases Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 29: World Recent Past, Current & Future Analysis for Communicable Diseases Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 30: World Historic Review for Communicable Diseases Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 31: World 13-Year Perspective for Communicable Diseases Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 32: World Recent Past, Current & Future Analysis for Injury Poisoning & External Causes Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 33: World Historic Review for Injury Poisoning & External Causes Group by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 34: World 13-Year Perspective for Injury Poisoning & External Causes Group by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 35: World Recent Past, Current & Future Analysis for Home Based Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 36: World Historic Review for Home Based Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 37: World 13-Year Perspective for Home Based Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 38: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 39: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 40: World 13-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
  • Table 41: World Recent Past, Current & Future Analysis for Community Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
  • Table 42: World Historic Review for Community Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
  • Table 43: World 13-Year Perspective for Community Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
CANADA
JAPAN
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
CHINA
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
EUROPE
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
FRANCE
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
GERMANY
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
ITALY
UNITED KINGDOM
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
AUSTRALIA
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
INDIA
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Palliative Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • African Palliative Care Association (APCA)
  • Asia Pacific Hospice Palliative Care Network (APHN)
  • Canadian Hospice Palliative Care Association (CHPCA)
  • Chinese Association for Life Care
  • European Association for Palliative Care (EAPC)
  • German Association for Palliative Medicine (DGP)
  • Hospice and Palliative Nurses Association (HPNA)
  • Hospice UK
  • Indian Association of Palliative Care (IAPC)
  • International Association for Hospice & Palliative Care (IAHPC)
  • Italian Society for Palliative Care (SICP)
  • Japanese Society for Palliative Medicine (JSPM)
  • Korean Society for Hospice and Palliative Care
  • Latin American Association for Palliative Care (ALCP)
  • National Hospice and Palliative Care Organization (NHPCO)
  • New Zealand Palliative Care Council
  • Palliative Care Australia
  • Palliative Care South Africa (PCSSA)
  • Singapore Hospice Council
  • Worldwide Hospice Palliative Care Alliance (WHPCA)

Table Information